Further, Zhi et al. 23 adopted proteomics coupled with an immune assay to identify DM-related biomarkers and found a significant increase in the expression level of adiponectin, insulin-like growth factor binding protein, C-reactive protein, and serum amyloid protein A in patients with DM. This evidence concerns the gene SAA1 and diabetes mellitus.